Skip to: Main Content Search Main Navigation Audience Navigation

A Diabetes-Free Society

Executive Board

The DI Executive Board is the internal contingent that will be consulted for DI activities.  The board will assist the Executive Director and Division Directors in making decisions as to DI activities and in making decisions regarding the allocation of DI resources on an annual basis.  The Executive Board will consist of:

Darlene Berryman, PhD, RD, LD, DI Executive Director and DI Co-Director, Research Division
Elizabeth Beverly, PhD, DI Co-Director, Research Division
Cheryl Howe, PhD, DI Director, Education Division
Frank Schwartz, MD, FACE, DI Co-Director, Clinical Division
Karen Bailey, MS, RD, LD, CDE, DI Co-Director, Clinical Division
Kathy Trace, MA, BSN, RN, DI Director, Outreach Division
Melissa Standley, MEd, DI Director of Operations
Jay Shubrook, DO, FACOFP, FAAFP, Specialty Medicine, HCOM DI Investigator Representative
Karen Coschigano, PhD, Biomedical Sciences, HCOM DI Investigator Representative
Robert Colvin, PhD, Biological Sciences, College of Arts & Sciences DI Affiliate Representative
Tobie Newberry, CNP, Community Health Programs, HCOM DI Collaborator Representative
Adam Jara, Graduate/Medical Student Representative
Chance Benner, Medical Student Representative
Brandon Riley, Undergraduate Student Representative
Shiyong Wu, PhD, Director, Edison Biotechnology Institute OU Institute Representative
Randy Leite, PhD, Dean, College of Health Sciences and Professions CHSP Dean Representative
John Brose, DO, Vice President for Health Affairs HCOM Dean Representative
Harvey Schwartz, MBA, Executive Director, CORE Healthcare Representative
Sharon Zimmerman, MPA, Executive Director of Constituent Relations for Health Affairs, HCOM Development Representative